Head, BioPharma RWE, Guardant Health
Biography
Naveen Kumar currently serves as Head of BioPharma Real World Evidence at Guardant Health, a leading precision oncology company focused on helping conquer cancer globally through the use of its proprietary blood tests, vast data sets and advanced analytics. Prior to joining Guardant, Naveen worked as Vice President and Chief Strategy Officer for M2Gen, a health informatics solutions company focused on accelerating the discovery and development of precision medicine. He has also worked in financial advisory and consulting roles serving the life sciences industry. Naveen holds a B.A. Economics with Honors from New York University and an M.Sc. Finance and Economics from the London School of Economics.
AI and Data Science Showcase:
Guardant Health
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through the use of its proprietary blood tests, vast data sets, and advanced analytics.
From ctDNA to RWE
This presentation will focus on how Guardant Health is leveraging its vast genomic database derived from ctDNA to enable unique RWE studies.
Session Abstract – PMWC 2020 Silicon Valley
Track 7 - January 22 9.00 A.M.-3.45 P.M.,Track 6 - January 23 11.15 A.M.-11.30 A.M.,Track 2 - January 24 11.15 A.M.-4.00 P.M.
The PMWC 2020 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
